S. BATIBAY Et Al. , "Immunogenicity and safety of the CoronoVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults," EULAR 2022 Congress , kopenhag, Denmark, 2022
BATIBAY, S. Et Al. 2022. Immunogenicity and safety of the CoronoVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults. EULAR 2022 Congress , (kopenhag, Denmark).
BATIBAY, S., Koçak Ulucaköy, r., GÜNENDİ, Z., FİDAN, I., BOZDAYI, G., & GÖĞÜŞ, F. N., (2022). Immunogenicity and safety of the CoronoVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults . EULAR 2022 Congress, kopenhag, Denmark
BATIBAY, SEVİLAY Et Al. "Immunogenicity and safety of the CoronoVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults," EULAR 2022 Congress, kopenhag, Denmark, 2022
BATIBAY, SEVİLAY Et Al. "Immunogenicity and safety of the CoronoVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults." EULAR 2022 Congress , kopenhag, Denmark, 2022
BATIBAY, S. Et Al. (2022) . "Immunogenicity and safety of the CoronoVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults." EULAR 2022 Congress , kopenhag, Denmark.
@conferencepaper{conferencepaper, author={SEVİLAY BATIBAY Et Al. }, title={Immunogenicity and safety of the CoronoVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults}, congress name={EULAR 2022 Congress}, city={kopenhag}, country={Denmark}, year={2022}}